Healthcare ETFs To Buy On Solid Q2 Earnings Expectations

Healthcare has been the second-best performing sector in the three-month time period driven by its non-cyclical nature, which provides a defensive tilt to the portfolio in a turbulent market against a rising M&A and positive regulatory backdrop.

A popular ETF like Health Care Select Sector SPDR Fund (XLV  - Free Reporthas gained 6.1%, while Vanguard Health Care ETF (VHT  - Free Report), iShares U.S. Healthcare ETF (IYH - Free Report) and Fidelity MSCI Health Care Index ETF (FHLC - Free Report) are up more than 7% each. The strength is likely to continue heading into the Q2 earnings season as some big names like Pfizer (PFE - Free Report) , Merck (MRK  - Free Report), Amgen (AMGN  - Free Report), AbbVie (ABBV  - Free Report), Gilead Sciences (GILD - Free Report) and Bristol-Myers Squibb (BMY - Free Report) are lined up to report this week and in the next. All these stocks collectively account for a 25% share in XLV, 23.3% in IYH, 21.6% in VHT and 21.2% in FHLC.

Let’s dig deeper into the earnings picture of these companies that would drive the performance of the above-mentioned funds in the coming days:

According to our methodology, a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), when combined with a positive Earnings ESP increases our chances of predicting an earnings beat, while a Zacks Rank #4 or 5 (Sell-rated) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Inside Our Surprise Prediction for These Stocks

Pfizer has a Zacks Rank #3 and an Earnings ESP of +0.89%, indicating a reasonable chance of beating estimates this quarter. The stock has seen no earnings estimate revision for to-be-reported quarter over the past 30 days and delivered an average positive earnings surprise of 5.23% for the past four quarters. It has a VGM Score of C. Pfizer is scheduled to report earnings on Jul 31, before the opening bell.

1 2
View single page >> |

Disclosure: contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.